Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria del Hospital Universitario La Paz (18)

2023

  1. Resolvin D2 Attenuates Cardiovascular Damage in Angiotensin II-Induced Hypertension

    Hypertension, Vol. 80, Núm. 1, pp. 84-96

  2. Trabectedin modulates macrophage polarization in the tumor-microenvironment. Role of KV1.3 and KV1.5 channels

    Biomedicine and Pharmacotherapy, Vol. 161

2021

  1. Clonogenic Assays to Detect Cell Fate in Mitotic Catastrophe

    Methods in Molecular Biology (Humana Press Inc.), pp. 227-239

  2. Kv1.5–kvβ1.3 recycling is pkc-dependent

    International Journal of Molecular Sciences, Vol. 22, Núm. 3, pp. 1-12

2019

  1. Clinical and molecular diagnosis of non-phosphomannomutase 2 N-linked congenital disorders of glycosylation in Spain

    Clinical Genetics, Vol. 95, Núm. 5, pp. 615-626

  2. Pioglitazone Modulates the Vascular Contractility in Hypertension by Interference with ET-1 Pathway

    Scientific Reports, Vol. 9, Núm. 1

2017

  1. Aluminum exposure at human dietary levels promotes vascular dysfunction and increases blood pressure in rats: A concerted action of NAD(P)H oxidase and COX-2

    Toxicology, Vol. 390, pp. 10-21

  2. DPAGT1-CDG: Functional analysis of diseasecausing pathogenic mutations and role of endoplasmic reticulum stress

    PLoS ONE, Vol. 12, Núm. 6

  3. Exercise Intervention in Pediatric Patients with Solid Tumors: The Physical Activity in Pediatric Cancer Trial

    Medicine and Science in Sports and Exercise, Vol. 49, Núm. 2, pp. 223-230

  4. Fludarabine inhibits KV1.3 currents in human B lymphocytes

    Frontiers in Pharmacology, Vol. 8, Núm. MAR

2016

  1. Molecular diagnosis of glycogen storage disease and disorders with overlapping clinical symptoms by massive parallel sequencing

    Genetics in Medicine, Vol. 18, Núm. 10, pp. 1037-1043

  2. Role of COX-2-derived PGE2 on vascular stiffness and function in hypertension

    British Journal of Pharmacology, Vol. 173, Núm. 9, pp. 1541-1555

2015

  1. Antisense-mediated therapeutic pseudoexon skipping in TMEM165-CDG

    Clinical Genetics, Vol. 87, Núm. 1, pp. 42-48

  2. Clinical relevance of the differential expression of the glycosyltransferase gene GCNT3 in colon cancer

    European Journal of Cancer, Vol. 51, Núm. 1, pp. 1-8

  3. Regulation of microRNA 183 by cyclooxygenase 2 in liver is DEAD-box helicase p68 (DDX5) dependent: Role in insulin signaling

    Molecular and Cellular Biology, Vol. 35, Núm. 14, pp. 2554-2567

  4. Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertension

    British Journal of Pharmacology, Vol. 172, Núm. 12, pp. 3159-3176

2014

  1. Genes associated with metabolic syndrome predict disease-free survival in stage II colorectal cancer patients. A novel link between metabolic dysregulation and colorectal cancer

    Molecular Oncology, Vol. 8, Núm. 8, pp. 1469-1481

  2. Pioglitazone reduces angiotensin II-induced COX-2 expression through inhibition of ROS production and ET-1 transcription in vascular cells from spontaneously hypertensive rats

    American Journal of Physiology - Heart and Circulatory Physiology, Vol. 306, Núm. 11